Copyright (C) 2023, Semrush Inc. This file is a part of Semrush Content Toolkit plugin for WordPress. Semrush Content Toolkit plugin for WordPress is free software: you can redistribute it and/or modify it under the terms of GNU General Public License as published by the Free Software Foundation, either version 2 of the License, or (at your opinion) any later version. Semrush Content Toolkit plugin for WordPress is distributed in the hope that it will be useful, but WITHOUT ANY WARRANTY; without even the implied warranty of MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE. See the GNU General Public License for more details. GNU GENERAL PUBLIC LICENSE Version 3, 29 June 2007 Copyright (C) 2007 Free Software Foundation, Inc. Everyone is permitted to copy and distribute verbatim copies of this license document, but changing it is not allowed. Preamble The GNU General Public License is a free, copyleft license for software and other kinds of works. The licenses for most software and other practical works are designed to take away your freedom to share and change the works. By contrast, the GNU General Public License is intended to guarantee your freedom to share and change all versions of a program--to make sure it remains free software for all its users. We, the Free Software Foundation, use the GNU General Public License for most of our software; it applies also to any other work released this way by its authors. You can apply it to your programs, too. When we speak of free software, we are referring to freedom, not price. Our General Public Licenses are designed to make sure that you have the freedom to distribute copies of free software (and charge for them if you wish), that you receive source code or can get it if you want it, that you can change the software or use pieces of it in new free programs, and that you know you can do these things. To protect your rights, we need to prevent others from denying you these rights or asking you to surrender the rights. Therefore, you have certain responsibilities if you distribute copies of the software, or if you modify it: responsibilities to respect the freedom of others. For example, if you distribute copies of such a program, whether gratis or for a fee, you must pass on to the recipients the same freedoms that you received. You must make sure that they, too, receive or can get the source code. And you must show them these terms so they know their rights. Developers that use the GNU GPL protect your rights with two steps: (1) assert copyright on the software, and (2) offer you this License giving you legal permission to copy, distribute and/or modify it. For the developers' and authors' protection, the GPL clearly explains that there is no warranty for this free software. For both users' and authors' sake, the GPL requires that modified versions be marked as changed, so that their problems will not be attributed erroneously to authors of previous versions. Some devices are designed to deny users access to install or run modified versions of the software inside them, although the manufacturer can do so. This is fundamentally incompatible with the aim of protecting users' freedom to change the software. The systematic pattern of such abuse occurs in the area of products for individuals to use, which is precisely where it is most unacceptable. Therefore, we have designed this version of the GPL to prohibit the practice for those products. If such problems arise substantially in other domains, we stand ready to extend this provision to those domains in future versions of the GPL, as needed to protect the freedom of users. Finally, every program is threatened constantly by software patents. States should not allow patents to restrict development and use of software on general-purpose computers, but in those that do, we wish to avoid the special danger that patents applied to a free program could make it effectively proprietary. To prevent this, the GPL assures that patents cannot be used to render the program non-free. The precise terms and conditions for copying, distribution and modification follow. TERMS AND CONDITIONS 0. Definitions. "This License" refers to version 3 of the GNU General Public License. "Copyright" also means copyright-like laws that apply to other kinds of works, such as semiconductor masks. "The Program" refers to any copyrightable work licensed under this License. Each licensee is addressed as "you". "Licensees" and "recipients" may be individuals or organizations. To "modify" a work means to copy from or adapt all or part of the work in a fashion requiring copyright permission, other than the making of an exact copy. The resulting work is called a "modified version" of the earlier work or a work "based on" the earlier work. A "covered work" means either the unmodified Program or a work based on the Program. To "propagate" a work means to do anything with it that, without permission, would make you directly or secondarily liable for infringement under applicable copyright law, except executing it on a computer or modifying a private copy. Propagation includes copying, distribution (with or without modification), making available to the public, and in some countries other activities as well. To "convey" a work means any kind of propagation that enables other parties to make or receive copies. Mere interaction with a user through a computer network, with no transfer of a copy, is not conveying. An interactive user interface displays "Appropriate Legal Notices" to the extent that it includes a convenient and prominently visible feature that (1) displays an appropriate copyright notice, and (2) tells the user that there is no warranty for the work (except to the extent that warranties are provided), that licensees may convey the work under this License, and how to view a copy of this License. If the interface presents a list of user commands or options, such as a menu, a prominent item in the list meets this criterion. 1. Source Code. The "source code" for a work means the preferred form of the work for making modifications to it. "Object code" means any non-source form of a work. A "Standard Interface" means an interface that either is an official standard defined by a recognized standards body, or, in the case of interfaces specified for a particular programming language, one that is widely used among developers working in that language. The "System Libraries" of an executable work include anything, other than the work as a whole, that (a) is included in the normal form of packaging a Major Component, but which is not part of that Major Component, and (b) serves only to enable use of the work with that Major Component, or to implement a Standard Interface for which an implementation is available to the public in source code form. A "Major Component", in this context, means a major essential component (kernel, window system, and so on) of the specific operating system (if any) on which the executable work runs, or a compiler used to produce the work, or an object code interpreter used to run it. The "Corresponding Source" for a work in object code form means all the source code needed to generate, install, and (for an executable work) run the object code and to modify the work, including scripts to control those activities. However, it does not include the work's System Libraries, or general-purpose tools or generally available free programs which are used unmodified in performing those activities but which are not part of the work. For example, Corresponding Source includes interface definition files associated with source files for the work, and the source code for shared libraries and dynamically linked subprograms that the work is specifically designed to require, such as by intimate data communication or control flow between those subprograms and other parts of the work. The Corresponding Source need not include anything that users can regenerate automatically from other parts of the Corresponding Source. The Corresponding Source for a work in source code form is that same work. 2. Basic Permissions. All rights granted under this License are granted for the term of copyright on the Program, and are irrevocable provided the stated conditions are met. This License explicitly affirms your unlimited permission to run the unmodified Program. The output from running a covered work is covered by this License only if the output, given its content, constitutes a covered work. This License acknowledges your rights of fair use or other equivalent, as provided by copyright law. You may make, run and propagate covered works that you do not convey, without conditions so long as your license otherwise remains in force. You may convey covered works to others for the sole purpose of having them make modifications exclusively for you, or provide you with facilities for running those works, provided that you comply with the terms of this License in conveying all material for which you do not control copyright. Those thus making or running the covered works for you must do so exclusively on your behalf, under your direction and control, on terms that prohibit them from making any copies of your copyrighted material outside their relationship with you. Conveying under any other circumstances is permitted solely under the conditions stated below. Sublicensing is not allowed; section 10 makes it unnecessary. 3. Protecting Users' Legal Rights From Anti-Circumvention Law. No covered work shall be deemed part of an effective technological measure under any applicable law fulfilling obligations under article 11 of the WIPO copyright treaty adopted on 20 December 1996, or similar laws prohibiting or restricting circumvention of such measures. When you convey a covered work, you waive any legal power to forbid circumvention of technological measures to the extent such circumvention is effected by exercising rights under this License with respect to the covered work, and you disclaim any intention to limit operation or modification of the work as a means of enforcing, against the work's users, your or third parties' legal rights to forbid circumvention of technological measures. 4. Conveying Verbatim Copies. You may convey verbatim copies of the Program's source code as you receive it, in any medium, provided that you conspicuously and appropriately publish on each copy an appropriate copyright notice; keep intact all notices stating that this License and any non-permissive terms added in accord with section 7 apply to the code; keep intact all notices of the absence of any warranty; and give all recipients a copy of this License along with the Program. You may charge any price or no price for each copy that you convey, and you may offer support or warranty protection for a fee. 5. Conveying Modified Source Versions. You may convey a work based on the Program, or the modifications to produce it from the Program, in the form of source code under the terms of section 4, provided that you also meet all of these conditions: a) The work must carry prominent notices stating that you modified it, and giving a relevant date. b) The work must carry prominent notices stating that it is released under this License and any conditions added under section 7. This requirement modifies the requirement in section 4 to "keep intact all notices". c) You must license the entire work, as a whole, under this License to anyone who comes into possession of a copy. This License will therefore apply, along with any applicable section 7 additional terms, to the whole of the work, and all its parts, regardless of how they are packaged. This License gives no permission to license the work in any other way, but it does not invalidate such permission if you have separately received it. d) If the work has interactive user interfaces, each must display Appropriate Legal Notices; however, if the Program has interactive interfaces that do not display Appropriate Legal Notices, your work need not make them do so. A compilation of a covered work with other separate and independent works, which are not by their nature extensions of the covered work, and which are not combined with it such as to form a larger program, in or on a volume of a storage or distribution medium, is called an "aggregate" if the compilation and its resulting copyright are not used to limit the access or legal rights of the compilation's users beyond what the individual works permit. Inclusion of a covered work in an aggregate does not cause this License to apply to the other parts of the aggregate. 6. Conveying Non-Source Forms. You may convey a covered work in object code form under the terms of sections 4 and 5, provided that you also convey the machine-readable Corresponding Source under the terms of this License, in one of these ways: a) Convey the object code in, or embodied in, a physical product (including a physical distribution medium), accompanied by the Corresponding Source fixed on a durable physical medium customarily used for software interchange. b) Convey the object code in, or embodied in, a physical product (including a physical distribution medium), accompanied by a written offer, valid for at least three years and valid for as long as you offer spare parts or customer support for that product model, to give anyone who possesses the object code either (1) a copy of the Corresponding Source for all the software in the product that is covered by this License, on a durable physical medium customarily used for software interchange, for a price no more than your reasonable cost of physically performing this conveying of source, or (2) access to copy the Corresponding Source from a network server at no charge. c) Convey individual copies of the object code with a copy of the written offer to provide the Corresponding Source. This alternative is allowed only occasionally and noncommercially, and only if you received the object code with such an offer, in accord with subsection 6b. d) Convey the object code by offering access from a designated place (gratis or for a charge), and offer equivalent access to the Corresponding Source in the same way through the same place at no further charge. You need not require recipients to copy the Corresponding Source along with the object code. If the place to copy the object code is a network server, the Corresponding Source may be on a different server (operated by you or a third party) that supports equivalent copying facilities, provided you maintain clear directions next to the object code saying where to find the Corresponding Source. Regardless of what server hosts the Corresponding Source, you remain obligated to ensure that it is available for as long as needed to satisfy these requirements. e) Convey the object code using peer-to-peer transmission, provided you inform other peers where the object code and Corresponding Source of the work are being offered to the general public at no charge under subsection 6d. A separable portion of the object code, whose source code is excluded from the Corresponding Source as a System Library, need not be included in conveying the object code work. A "User Product" is either (1) a "consumer product", which means any tangible personal property which is normally used for personal, family, or household purposes, or (2) anything designed or sold for incorporation into a dwelling. In determining whether a product is a consumer product, doubtful cases shall be resolved in favor of coverage. For a particular product received by a particular user, "normally used" refers to a typical or common use of that class of product, regardless of the status of the particular user or of the way in which the particular user actually uses, or expects or is expected to use, the product. A product is a consumer product regardless of whether the product has substantial commercial, industrial or non-consumer uses, unless such uses represent the only significant mode of use of the product. "Installation Information" for a User Product means any methods, procedures, authorization keys, or other information required to install and execute modified versions of a covered work in that User Product from a modified version of its Corresponding Source. The information must suffice to ensure that the continued functioning of the modified object code is in no case prevented or interfered with solely because modification has been made. If you convey an object code work under this section in, or with, or specifically for use in, a User Product, and the conveying occurs as part of a transaction in which the right of possession and use of the User Product is transferred to the recipient in perpetuity or for a fixed term (regardless of how the transaction is characterized), the Corresponding Source conveyed under this section must be accompanied by the Installation Information. But this requirement does not apply if neither you nor any third party retains the ability to install modified object code on the User Product (for example, the work has been installed in ROM). The requirement to provide Installation Information does not include a requirement to continue to provide support service, warranty, or updates for a work that has been modified or installed by the recipient, or for the User Product in which it has been modified or installed. Access to a network may be denied when the modification itself materially and adversely affects the operation of the network or violates the rules and protocols for communication across the network. Corresponding Source conveyed, and Installation Information provided, in accord with this section must be in a format that is publicly documented (and with an implementation available to the public in source code form), and must require no special password or key for unpacking, reading or copying. 7. Additional Terms. "Additional permissions" are terms that supplement the terms of this License by making exceptions from one or more of its conditions. Additional permissions that are applicable to the entire Program shall be treated as though they were included in this License, to the extent that they are valid under applicable law. If additional permissions apply only to part of the Program, that part may be used separately under those permissions, but the entire Program remains governed by this License without regard to the additional permissions. When you convey a copy of a covered work, you may at your option remove any additional permissions from that copy, or from any part of it. (Additional permissions may be written to require their own removal in certain cases when you modify the work.) You may place additional permissions on material, added by you to a covered work, for which you have or can give appropriate copyright permission. Notwithstanding any other provision of this License, for material you add to a covered work, you may (if authorized by the copyright holders of that material) supplement the terms of this License with terms: a) Disclaiming warranty or limiting liability differently from the terms of sections 15 and 16 of this License; or b) Requiring preservation of specified reasonable legal notices or author attributions in that material or in the Appropriate Legal Notices displayed by works containing it; or c) Prohibiting misrepresentation of the origin of that material, or requiring that modified versions of such material be marked in reasonable ways as different from the original version; or d) Limiting the use for publicity purposes of names of licensors or authors of the material; or e) Declining to grant rights under trademark law for use of some trade names, trademarks, or service marks; or f) Requiring indemnification of licensors and authors of that material by anyone who conveys the material (or modified versions of it) with contractual assumptions of liability to the recipient, for any liability that these contractual assumptions directly impose on those licensors and authors. All other non-permissive additional terms are considered "further restrictions" within the meaning of section 10. If the Program as you received it, or any part of it, contains a notice stating that it is governed by this License along with a term that is a further restriction, you may remove that term. If a license document contains a further restriction but permits relicensing or conveying under this License, you may add to a covered work material governed by the terms of that license document, provided that the further restriction does not survive such relicensing or conveying. If you add terms to a covered work in accord with this section, you must place, in the relevant source files, a statement of the additional terms that apply to those files, or a notice indicating where to find the applicable terms. Additional terms, permissive or non-permissive, may be stated in the form of a separately written license, or stated as exceptions; the above requirements apply either way. 8. Termination. You may not propagate or modify a covered work except as expressly provided under this License. Any attempt otherwise to propagate or modify it is void, and will automatically terminate your rights under this License (including any patent licenses granted under the third paragraph of section 11). However, if you cease all violation of this License, then your license from a particular copyright holder is reinstated (a) provisionally, unless and until the copyright holder explicitly and finally terminates your license, and (b) permanently, if the copyright holder fails to notify you of the violation by some reasonable means prior to 60 days after the cessation. Moreover, your license from a particular copyright holder is reinstated permanently if the copyright holder notifies you of the violation by some reasonable means, this is the first time you have received notice of violation of this License (for any work) from that copyright holder, and you cure the violation prior to 30 days after your receipt of the notice. Termination of your rights under this section does not terminate the licenses of parties who have received copies or rights from you under this License. If your rights have been terminated and not permanently reinstated, you do not qualify to receive new licenses for the same material under section 10. 9. Acceptance Not Required for Having Copies. You are not required to accept this License in order to receive or run a copy of the Program. Ancillary propagation of a covered work occurring solely as a consequence of using peer-to-peer transmission to receive a copy likewise does not require acceptance. However, nothing other than this License grants you permission to propagate or modify any covered work. These actions infringe copyright if you do not accept this License. Therefore, by modifying or propagating a covered work, you indicate your acceptance of this License to do so. 10. Automatic Licensing of Downstream Recipients. Each time you convey a covered work, the recipient automatically receives a license from the original licensors, to run, modify and propagate that work, subject to this License. You are not responsible for enforcing compliance by third parties with this License. An "entity transaction" is a transaction transferring control of an organization, or substantially all assets of one, or subdividing an organization, or merging organizations. If propagation of a covered work results from an entity transaction, each party to that transaction who receives a copy of the work also receives whatever licenses to the work the party's predecessor in interest had or could give under the previous paragraph, plus a right to possession of the Corresponding Source of the work from the predecessor in interest, if the predecessor has it or can get it with reasonable efforts. You may not impose any further restrictions on the exercise of the rights granted or affirmed under this License. For example, you may not impose a license fee, royalty, or other charge for exercise of rights granted under this License, and you may not initiate litigation (including a cross-claim or counterclaim in a lawsuit) alleging that any patent claim is infringed by making, using, selling, offering for sale, or importing the Program or any portion of it. 11. Patents. A "contributor" is a copyright holder who authorizes use under this License of the Program or a work on which the Program is based. The work thus licensed is called the contributor's "contributor version". A contributor's "essential patent claims" are all patent claims owned or controlled by the contributor, whether already acquired or hereafter acquired, that would be infringed by some manner, permitted by this License, of making, using, or selling its contributor version, but do not include claims that would be infringed only as a consequence of further modification of the contributor version. For purposes of this definition, "control" includes the right to grant patent sublicenses in a manner consistent with the requirements of this License. Each contributor grants you a non-exclusive, worldwide, royalty-free patent license under the contributor's essential patent claims, to make, use, sell, offer for sale, import and otherwise run, modify and propagate the contents of its contributor version. In the following three paragraphs, a "patent license" is any express agreement or commitment, however denominated, not to enforce a patent (such as an express permission to practice a patent or covenant not to sue for patent infringement). To "grant" such a patent license to a party means to make such an agreement or commitment not to enforce a patent against the party. If you convey a covered work, knowingly relying on a patent license, and the Corresponding Source of the work is not available for anyone to copy, free of charge and under the terms of this License, through a publicly available network server or other readily accessible means, then you must either (1) cause the Corresponding Source to be so available, or (2) arrange to deprive yourself of the benefit of the patent license for this particular work, or (3) arrange, in a manner consistent with the requirements of this License, to extend the patent license to downstream recipients. "Knowingly relying" means you have actual knowledge that, but for the patent license, your conveying the covered work in a country, or your recipient's use of the covered work in a country, would infringe one or more identifiable patents in that country that you have reason to believe are valid. If, pursuant to or in connection with a single transaction or arrangement, you convey, or propagate by procuring conveyance of, a covered work, and grant a patent license to some of the parties receiving the covered work authorizing them to use, propagate, modify or convey a specific copy of the covered work, then the patent license you grant is automatically extended to all recipients of the covered work and works based on it. A patent license is "discriminatory" if it does not include within the scope of its coverage, prohibits the exercise of, or is conditioned on the non-exercise of one or more of the rights that are specifically granted under this License. You may not convey a covered work if you are a party to an arrangement with a third party that is in the business of distributing software, under which you make payment to the third party based on the extent of your activity of conveying the work, and under which the third party grants, to any of the parties who would receive the covered work from you, a discriminatory patent license (a) in connection with copies of the covered work conveyed by you (or copies made from those copies), or (b) primarily for and in connection with specific products or compilations that contain the covered work, unless you entered into that arrangement, or that patent license was granted, prior to 28 March 2007. Nothing in this License shall be construed as excluding or limiting any implied license or other defenses to infringement that may otherwise be available to you under applicable patent law. 12. No Surrender of Others' Freedom. If conditions are imposed on you (whether by court order, agreement or otherwise) that contradict the conditions of this License, they do not excuse you from the conditions of this License. If you cannot convey a covered work so as to satisfy simultaneously your obligations under this License and any other pertinent obligations, then as a consequence you may not convey it at all. For example, if you agree to terms that obligate you to collect a royalty for further conveying from those to whom you convey the Program, the only way you could satisfy both those terms and this License would be to refrain entirely from conveying the Program. 13. Use with the GNU Affero General Public License. Notwithstanding any other provision of this License, you have permission to link or combine any covered work with a work licensed under version 3 of the GNU Affero General Public License into a single combined work, and to convey the resulting work. The terms of this License will continue to apply to the part which is the covered work, but the special requirements of the GNU Affero General Public License, section 13, concerning interaction through a network will apply to the combination as such. 14. Revised Versions of this License. The Free Software Foundation may publish revised and/or new versions of the GNU General Public License from time to time. Such new versions will be similar in spirit to the present version, but may differ in detail to address new problems or concerns. Each version is given a distinguishing version number. If the Program specifies that a certain numbered version of the GNU General Public License "or any later version" applies to it, you have the option of following the terms and conditions either of that numbered version or of any later version published by the Free Software Foundation. If the Program does not specify a version number of the GNU General Public License, you may choose any version ever published by the Free Software Foundation. If the Program specifies that a proxy can decide which future versions of the GNU General Public License can be used, that proxy's public statement of acceptance of a version permanently authorizes you to choose that version for the Program. Later license versions may give you additional or different permissions. However, no additional obligations are imposed on any author or copyright holder as a result of your choosing to follow a later version. 15. Disclaimer of Warranty. THERE IS NO WARRANTY FOR THE PROGRAM, TO THE EXTENT PERMITTED BY APPLICABLE LAW. EXCEPT WHEN OTHERWISE STATED IN WRITING THE COPYRIGHT HOLDERS AND/OR OTHER PARTIES PROVIDE THE PROGRAM "AS IS" WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. THE ENTIRE RISK AS TO THE QUALITY AND PERFORMANCE OF THE PROGRAM IS WITH YOU. SHOULD THE PROGRAM PROVE DEFECTIVE, YOU ASSUME THE COST OF ALL NECESSARY SERVICING, REPAIR OR CORRECTION. 16. Limitation of Liability. IN NO EVENT UNLESS REQUIRED BY APPLICABLE LAW OR AGREED TO IN WRITING WILL ANY COPYRIGHT HOLDER, OR ANY OTHER PARTY WHO MODIFIES AND/OR CONVEYS THE PROGRAM AS PERMITTED ABOVE, BE LIABLE TO YOU FOR DAMAGES, INCLUDING ANY GENERAL, SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES ARISING OUT OF THE USE OR INABILITY TO USE THE PROGRAM (INCLUDING BUT NOT LIMITED TO LOSS OF DATA OR DATA BEING RENDERED INACCURATE OR LOSSES SUSTAINED BY YOU OR THIRD PARTIES OR A FAILURE OF THE PROGRAM TO OPERATE WITH ANY OTHER PROGRAMS), EVEN IF SUCH HOLDER OR OTHER PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. 17. Interpretation of Sections 15 and 16. If the disclaimer of warranty and limitation of liability provided above cannot be given local legal effect according to their terms, reviewing courts shall apply local law that most closely approximates an absolute waiver of all civil liability in connection with the Program, unless a warranty or assumption of liability accompanies a copy of the Program in return for a fee. END OF TERMS AND CONDITIONS How to Apply These Terms to Your New Programs If you develop a new program, and you want it to be of the greatest possible use to the public, the best way to achieve this is to make it free software which everyone can redistribute and change under these terms. To do so, attach the following notices to the program. It is safest to attach them to the start of each source file to most effectively state the exclusion of warranty; and each file should have at least the "copyright" line and a pointer to where the full notice is found. Copyright (C) This program is free software: you can redistribute it and/or modify it under the terms of the GNU General Public License as published by the Free Software Foundation, either version 3 of the License, or (at your option) any later version. This program is distributed in the hope that it will be useful, but WITHOUT ANY WARRANTY; without even the implied warranty of MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE. See the GNU General Public License for more details. You should have received a copy of the GNU General Public License along with this program. If not, see . Also add information on how to contact you by electronic and paper mail. If the program does terminal interaction, make it output a short notice like this when it starts in an interactive mode: Copyright (C) This program comes with ABSOLUTELY NO WARRANTY; for details type `show w'. This is free software, and you are welcome to redistribute it under certain conditions; type `show c' for details. The hypothetical commands `show w' and `show c' should show the appropriate parts of the General Public License. Of course, your program's commands might be different; for a GUI interface, you would use an "about box". You should also get your employer (if you work as a programmer) or school, if any, to sign a "copyright disclaimer" for the program, if necessary. For more information on this, and how to apply and follow the GNU GPL, see . The GNU General Public License does not permit incorporating your program into proprietary programs. If your program is a subroutine library, you may consider it more useful to permit linking proprietary applications with the library. If this is what you want to do, use the GNU Lesser General Public License instead of this License. But first, please read . Outpatient Mental Health - South Florida | Frequently Asked Questions

FAQ – Outpatient Mental Health in South Florida

Struggling with the effects of a mental health disorder can feel overwhelming. Choosing the treatment that is right for you is of utmost importance in winning recovery and regaining your life. Neuroscience Institute offers the latest treatments as part of our complete array of services for outpatient mental health near South Florida.

From depression to anxiety, post-traumatic stress disorder (PTSD) to substance use disorder, our compassionate, individualized continuum of care has proven successful for many. Come see what we have to offer.

Psychiatry + Psychiatric Evaluations

When deciding it’s finally time to explore options for treating mental health, it’s normal to have questions about what to expect. It’s important to distinguish between a psychiatric evaluation and a psychological evaluation before seeking treatment. Fortunately, our psychiatric evaluations for outpatient mental health around South Florida will help you decide which treatment is right for you when seeking help.

What is a Psychiatric Evaluation?

A psychiatric evaluation is a diagnostic tool used to assess where you are at the start of treatment. It can help the psychiatrist determine if there are any issues with your behavior, memory, or thought processes. In the event there are multiple areas of focus, the psychiatric evaluation helps identify the psychiatrist’s triage needs. Additionally, they can plan an appropriate course of treatment.

Types of Psychiatric Evaluations in South Florida

When asking what is a psychiatric evaluation, it’s important to know that there are three primary types of psychiatric evaluations that are used under varying circumstances. These are:

Emergency Evaluation

Emergency evaluations are performed only under extraordinary circumstances. This is almost always when an individual’s health and safety are an immediate concern. Thus, individuals may:

  • Be uncooperative, agitated, or violent
  • Show signs of confusion or hallucinations
  • Pose a risk to themselves, family, or other people
  • Pose a threat of self-harm or harm to someone else

Emergency evaluations are performed in the emergency room and are performed first by a non-psychiatric physician and then a psychiatrist. The vast majority of people who need an emergency evaluation have experienced recent trauma or are under the influence of drugs.

General Psychiatric Evaluation

The general psychiatric evaluation is a general assessment to determine if an individual has a mental illness or illnesses that require psychiatric care. The evaluation can take as little as 30 minutes but may last 90 or more minutes. The longer the evaluation, the more comprehensive the data collected. As a result, this provides a more detailed picture for the psychiatrist.

This assessment involves a series of questions and a review of the person’s medical history. As well, they may involve routine lab work, as well as talking with the individual’s friends and loved ones.

Clinical Consultation

The clinical consultation is a diagnostic tool to help assess individuals who are unable to request a psychiatric evaluation on their own. Some mental disorders severely impact the way a person thinks or behaves. The consultation helps to inform them of treatment options. Last but not least, a medical doctor or family member requests clinical consultations.

What is a Psychological Evaluation?

A psychological evaluation is a mental health assessment or screening a psychologist performs. This evaluation helps diagnose mental health disorders, such as:

  • ADHD
  • Anxiety
  • Bipolar disorder
  • Dementia
  • Intellectual disorders
  • Schizophrenia
  • Substance abuse disorders

The evaluation helps the psychologist determine what symptoms are present. It can also help them understand the severity of the symptoms and how long they have been present. It can also help the psychologist uncover if there are any underlying causes for mental health disorders. In addition, psychological testing can help determine:

  • Existing coping strategies
  • Learning disabilities
  • Personality style of the individual
  • Issues that may be influencing behavior

Types Of Psychological Evaluations

There are four primary psychological evaluations during outpatient mental health around South Florida:

Behavioral Assessment

This diagnostic tool helps psychologists get to the root of what may be causing problematic behaviors—especially if the reason is unclear. It assesses behaviors and emotions.

Take the first step towards healing with Neuroscience Institute

Our approach uses active behavioral research coupled with proven and effective evidence-based therapeutic approaches to help our clients find meaningful recovery from mental illness symptoms. Call us today to speak with a caring professional and take the first step towards mental wellness.

Clinical Interview

Structured clinical and clinical diagnostic interviews are two types of clinical interviews. These help to provide a clearer picture of underlying causes to gain a more accurate mental health diagnosis.

Personality Assessment

This tool is used to help inform treatment by taking into account the genetic, social, and environmental aspects of the person’s personality.

Intelligence Testing

Intelligence tests and neuropsychological assessments are two primary tests to measure intelligence. This test assesses cognitive abilities and intellectual potential.

Psychiatric Evaluation vs Psychological Evaluation: What’s the Difference?

When considering your treatment options, it’s important to understand the difference between a psychiatric evaluation and a psychological evaluation. A psychiatrist performs a psychiatric evaluation. They are considered a medical doctor as this is considered a medical procedure. These types of evaluations take into account your mental and physical health. Treatment is holistic, focusing on biological and pharmaceutical therapies.

On the other hand, psychologists perform psychological evaluations. They are licensed practitioners, but not medical doctors. Evaluations may consist of structured tests and interviews with the individual—and they may include the family. They focus on the psychological, social, and emotional aspects of a person’s health, but do not assess physical symptoms. Treatment generally focuses on behavioral therapies.

When considering which option is best for you, it’s helpful to ask yourself:

  • Do I want to focus on mental or psychical symptoms or both?
  • Will I need medication?
  • Do I want help getting educational or employment accommodations for a disability?
  • What kind of treatment or therapy do I want?

Psychiatric Evaluations in South Florida

Getting help for your mental health disorder is a brave first step in living a meaningful and fulfilling life. Neuroscience Institute provides psychiatry services for outpatient mental health around South Florida. We’re here to help you find relief from mental health symptoms and to get you on the road to recovery.

Ketamine Infusion Treatment

FDA-approved and shown effective through extensive research, Ketamine Infusion Treatment treats symptoms of depression, PTSD, and trauma and has shown to have a positive impact on those living with suicidal ideation. Perhaps best of all, the side effects of Ketamine are very few, if any, and usually very mild. NRI provides Ketamine Infusion Treatment as part of its array of outpatient services.

Ketamine is a derivative of phencyclidine. It is an anesthetic drug developed in 1962 and has been used in many different settings. It is a very different type of anesthetic in its own category. Ketamine acts as an antagonist of the NMDA (N-methyl-D-aspartate) receptor to target glutamate, which is an excitatory amino acid transmitter.

Ketamine has been used to induce and maintain anesthesia for more than 30 years and is on the World Health Organization’s List of Essential Medicines. Additionally, Ketamine is FDA-approved and boasts a safe track record. Unlike other drugs (opioids, benzodiazepines, propofol), Ketamine does not cause respiratory depression while maintaining its sedative effects.

Through extensive research, Ketamine has proven an effective treatment for depression, PTSD, and trauma. It also has been shown to be beneficial to the detox process. It is particularly effective in treatment that has not responded to other therapies and medication interventions. Ketamine has a beneficial impact on suicidal ideation. However, Ketamine is not indicated for schizophrenia.

Yes. Over the last two decades, researchers have consistently found that low doses of Ketamine, when administered with an IV over a short period of time, produce effects that can counteract symptoms of depression, PTSD, trauma, and anxiety. These studies originated from such reputable institutions as Yale, the National Institute of Mental Health, and Mayo Clinic, to name a few.

Research suggests that, by blocking the NMDA receptors in the brain, Ketamine tells the brain to increase the production of signaling proteins in the prefrontal cortex. The prefrontal cortex is critical in the regulation of mood. Ketamine promotes the growth of new pathways, resulting in greater connectivity in the prefrontal cortex. Thus, this is the reason for its rapid anti-depressant effects.

Ketamine’s effect can begin to take place between one to 12 hours after the first infusion. Patients may continue to experience “bad periods” either during or after the infusions. Overall, mood symptoms trend positive following serial ketamine infusions.

A series of infusions have been shown to have a more positive and longer-lasting effect than singular infusions. The typical number of Ketamine infusions is six over a two or three-week period. Some choose to have maintenance of the Ketamine infusion over a longer period of time. Our care is personalized to each individual.

The length of response to Ketamine infusion varies with each patient. Patients may feel symptoms return in the four to six months following the initial series. Patients may receive a booster maintenance infusion of Ketamine at this time to stave off symptom relapse. Of course, booster maintenance is personalized to each patient based on initial infusion, patient history, and current health status. Thus, each patient continues with outpatient mental health around South Florida based on their needs and symptoms.

Most individuals experience few to zero side effects. Those who do may experience mild nausea, drowsiness, headache, blurry vision, dizziness, increased blood pressure, dissociation, and vivid dreams. However, nearly all of these symptoms disappear within 15 minutes after infusion. Also, an adjustment to the infusion dose of Ketamine can control these symptoms.

The answer is no, provided a trained medical professional prescribes Ketamine to treat legitimate medical conditions. However, as with any medication, people can abuse it at higher doses. In fact, the amount used for treatment is only eight to 12% of the amount used when Ketamine was abused as a “club drug” in the 1990s. However, even at high doses, Ketamine does not cause physical dependence.

You will arrive, check in, and fill out paperwork. Your provider will ask questions as a pre-treatment assessment. They take vital signs before placing the IV, give anti-nausea medication, and the infusion begins.

Ketamine infusion lasts for approximately 45 and 60 minutes. After the infusion, you will relax in your recliner or bed (if desired) for approximately 20 minutes. Then someone can drive you home. The initial visit—with paperwork, infusion, and recovery—takes approximately two hours. Subsequent infusions take less than 90 minutes, typically.

All you have to do is sit or lie back and relax. The staff does everything to make sure you have the most comfortable and relaxing experience with your infusion. You can watch our large-screen TV, and listen to music with provided headphones that connect to your cell phone. We recommend calming spa-like music. You can use earplugs and a sleep mask for complete peace and quiet. The choice is yours. Your provider will remain available.

You should not stop taking your psychiatric or other medications at the time of your infusions. You should not adjust the dose or frequency of any med without consulting your physician.

There are some meds to avoid if receiving a Ketamine infusion. Aminophylline for asthma or COPD runs a risk of seizures. Lamictal may affect the dose of Ketamine. No MAOIs within two weeks of infusion. Patients taking large doses of benzos may experience a reduced response to Ketamine. Taking SSRIs and Tricyclics should continue as prescribed.

At this time, Ketamine infusions are not covered by most insurance providers. While Ketamine is an FDA-approved anesthetic medication and backed by extensive research, it is not yet approved for the treatment of depression or other psychiatric conditions.

Conditions preventing the treatment of Ketamine infusions include uncontrolled high blood pressure, uncontrolled hyperthyroidism, and severe pulmonary issues. Additionally, they include seizure disorders, severe glaucoma, and severe cardiac issues. Some conditions may require clearance from a primary care physician.

You should not stop taking your psychiatric or other medications at the time of your infusions. You should not adjust the dose or frequency of any med without consulting your physician.

There are some meds to avoid if receiving a Ketamine infusion. Aminophylline for asthma or COPD runs a risk of seizures. Lamictal may affect the dose of Ketamine. No MAOIs within two weeks of infusion. Patients taking large doses of benzos may experience a reduced response to Ketamine. Taking SSRIs and Tricyclics should continue as prescribed.

No. You should maintain contact with your psychiatrist, therapist, or primary care physician during and after treatment for ongoing medical and mental health needs. Ketamine infusions allow the patient to become “unstuck” in rigid negative thought patterns and behaviors. This empowers the patient to re-engage with life and the therapeutic process. It also allows other psychiatric medications to have an effect.

Yes. You are not allowed to drive yourself home from our outpatient mental health center near South Florida, so please make arrangements. Do not operate heavy machinery or make any significant life decisions for 24 hours. Please do not eat a large meal for two hours prior to the appointment. You may drink clear liquids up to one hour prior to the appointment.

Botox Treatment to Forehead and Eyebrow

Who could have known that Botox treatment—so often used in past decades for the reduction of facial wrinkles—is an effective treatment for various mental health disorders? One of the major positives of this groundbreaking treatment is its effectiveness. For example, symptoms of depression, PTSD, and trauma are significantly reduced for up to six months after one injection to the forehead and brow region.

Botox is a drug made from a toxin produced by the bacterium Clostridium botulinum.

Extensive research suggests that suggests Botox can ease the symptoms of depression.

Yes. For the past five to 10 years, there has been statistically significant research that Botox is a safe and effective treatment for patients living with major depression. The research is in journals like the National Institute of Health.

Botox works by weakening or paralyzing specific muscles or by blocking certain nerves that release acetylcholine.

Botox’s effects can be felt immediately upon injection to the glabella, or between and above eyebrows and around the forehead.

An initial treatment to the eyebrow and forehead should last three to six months. Additional treatment appointments can be made three to six months after each treatment. These additional treatments can be part of a patient’s plan for outpatient mental health near South Florida.

Most individuals experience few to zero side effects. However, possible side effects include pain and swelling or bruising at injection sites, headache or flu-like symptoms, droopy eyelid or brow, eye dryness, or excessive tearing.

At this time, Botox is not covered by most insurance providers. While Botox is FDA-approved for some conditions and backed by extensive research, it is not yet approved for the treatment of depression or other psychiatric conditions.

No. You should not stop taking your psychiatric and other medications at the time of Botox injection. You should not adjust dose or frequency of any med without consulting your physician.

There are some meds that should be avoided if receiving Botox, due to their possibly risky interactions. These include certain antibiotics (aminoglycosides such as gentamicin and polymyxin), anticoagulants such as Coumadin, Alzheimer’s drugs like galantamine, rivastigmine, tacrine; and myasthenia gravis drugs like ambenonium, pyridostigmine, and quinidine.

No. You should maintain contact with your psychiatrist, therapist, or primary care physician during and after treatment for ongoing medical and mental health needs. Propofol treatments may allow the patient to become “unstuck” in rigid negative thought patterns and behaviors. This empowers the patient to re-engage with life and the therapeutic process. It also allows other psychiatric medications to have an effect.

Yes. After your Botox injection (and for the next 24 hours):

  • Do not rub your face
  • Do not take a nap right after your appointment
  • Avoid strenuous exercise
  • Do not drink alcoholic beverages
  • Do not take blood thinners
  • Do not wash your face
  • Avoid the sun and the heat

IV Sedation

A good night’s sleep is crucial to one’s living one’s best life. Chronic insomnia, or long-term patterns of difficulty sleeping, therefore present as a major life difficulty. In other words, no one should have to go through life poorly rested. That’s why NRI offers IV Sedation. Recent research suggests that these low-dose propofol infusions provide safe, effective treatment for people with chronic insomnia.

Propofol is a drug that restricts the movement of a key protein known as syntaxin 1A. This protein is required at the synapse of all neurons and causes a sedative effect.

Low-dose propofol infusions have been shown to effectively treat chronic, refractory insomnia.

Yes. Propofol IV infusion is given at a low-dose, typically 12% to 20%. A licensed and trained anesthesia provider with at least 20 years of experience administers the propofol infusion. The patient receives oxygen for support, vital signs measured frequently throughout a procedure, and gets continuous and uninterrupted monitoring.

Yes. The last five to eight years have seen statistically significant research suggesting that low-dose propofol infusion is a safe and effective treatment for patients with chronic insomnia. The research is published in journals such as the National Institute of Health, with studies conducted here in Florida.

Propofol therapy is safe and effective in restoring normal sleep to patients through a series of consecutive, medically-induced evenings.

The onset of sleep with propofol is immediate. As mentioned, treatment consists of a series of consecutive evenings. By the end of treatment, the brain and body are retrained for continuous, high-quality sleep.

The treatment consists of five consecutive evenings of the propofol IV infusion over a course of two hours.

There aren’t many. In this setting, propofol rarely produces rapid or profound decreases in the level of consciousness and cardiorespiratory function. These may be treated by our licensed anesthesia provider. Of note, propofol, when given as an IV infusion, actually has a strong anti-nausea property. However, antiemetics will still be administered with an IV.

At this time, propofol is not covered by most insurance providers. While FDA-approved for some procedures and backed by extensive research, propofol is not yet approved for the treatment of chronic insomnia.

Patients with severe sleep apnea or difficult airways, or those taking other CNS depressant medications on a daily basis, are prevented from propofol treatments. Those who are also prevented are people with severe hypertension, liver disease, severe cardiac disease, and allergies to eggs and egg products, soybeans or soy products.

You should not stop taking your psychiatric and other medications at the time of propofol treatments. You should not adjust dose or frequency of any med without consulting your physician.

No. You should maintain contact with your psychiatrist, therapist, or primary care physician during and after treatment for ongoing medical and mental health needs. Propofol treatments may allow the patient to become “unstuck” in rigid negative thought patterns and behaviors.

This empowers the patient to re-engage with life and the therapeutic process. It also allows other psychiatric medications to have an effect. Thus, IV sedation is just one part of treatment for outpatient mental health near South Florida.

Yes. Do not drive or do anything that requires you to be awake and alert for 24 hours after treatment. Please arrange for transportation. Do not operate heavy machinery or make significant life decisions for 24 hours. Do not eat for six hours before treatment. You may drink only clear liquids up to two hours before treatment.

Benzodiazepine Treatment

Depending on the type of substance used and the patient’s overall physical health, symptoms of drug withdrawal cover the gambit from the merely uncomfortable to the fatal. NRI’s outpatient services now include benzodiazepine treatment for withdrawal. At NRI we utilize Ativan, a long-lasting benzo that takes hold for several days in the body, making it more useful in managing withdrawal symptoms than most other medications.

Ativan is a benzodiazepine, or “benzo.” It works by attaching to gamma -aminobutyric acid (GABA) receptors. GABA is a neurotransmitter used in the brain and nervous system and works by slowing down signals sent through the Central Nervous System (CNS). Ativan attaches to GABA receptors and increases the signals sent by GABA to the body.

Ativan is a widely used medication. It is utilized often in the treatment of anxiety, status epilepticus (emergent seizures), and anxiety before surgery/procedures. Ativan is also used for other indications, including detox and the treatment of withdrawal symptoms. People undergoing detox from alcohol and other benzodiazepines tend to respond well to Ativan, since, like Ativan, these substances also affect the GABA transmission in the CNS.

When a person undergoes withdrawal, their GABA receptors are not working well, which creates symptoms like anxiety and seizures. Ativan makes the GABA receptors more sensitive, helping to reduce withdrawal symptoms. Also, Ativan is a longer-acting benzodiazepine. This means it takes several days to leave the body. This makes it more useful than other medications, which metabolize quickly and leave the body vulnerable to symptoms of drug withdrawal. 

Detoxing from opioids, alcohol, and benzodiazepines affects the heart, breathing, and other essential bodily functions. NRPA offers medical detox for people detoxing from alcohol, opioids, benzodiazepines, stimulants, marijuana, and prescription drugs.

The benefits of medical detox include reducing the intensity of withdrawal symptoms. This occurs safely under the supervision of medical professionals, allowing the patient to focus on their recovery and prepare for the rehab process. In addition, withdrawal from certain substances without medical supervision can cause seizures, disorientation, dehydration, depression, nausea and, in some cases, death. NRPA aims to help you stay as comfortable as possible while undergoing addiction treatment.

The benefits of detox with NRPA include a shorter detox period, no required hospital stay, and customized medications to reduce discomfort. As well, they get access to caring medical professionals and access to recovery support services. After all, drug withdrawal can be dangerous without medical intervention. NRPA can help patients avoid or decrease the negative effects of withdrawal. These negative effects include insomnia, anxiety, headaches, diarrhea, tremors, hallucinations, psychosis, DTs, and seizures.

The detox programs typically run between three and 10 days. However, overall detox can very depend on several factors, including the type of detox program, which substance or substances have been abused, the length of substance abuse, the quantity consumed, age, gender, medical history, and the presence of pre-existing health issues.

In many cases, insurance provides partial or full coverage of medical detox. Still, you will want to speak with your individual insurance provider to see which type of coverage is offered for medical detox programs.

No! You should maintain contact with your psychiatrist, therapist, or primary care physician during and after detox for ongoing medical and mental health treatment. You can also continue with a psychiatrist during outpatient mental health near South Florida.

NRPA offers three different types of medical detox. Which type is right for you depends on multiple factors, including your specific needs:

  1. Ketamine IV infusion at NRPA. Typically, three to six visits with each visit lasting one to two hours in a comfortable, spa-like setting.
  2. Ativan given in combination of IV and by mouth. Day one takes place at NRPA and includes two IV doses and one oral dose of Ativan given in a comfortable spa-like setting. The patient is then sent home with oral Ativan taken on day two. NRPA medical professionals determine additional appointments with an extended detox regimen.
  3. Taken orally, Ativan tapers daily over the next 10 days. The treatment is outpatient but the patient must come in daily for a quick assessment and receive the next day’s Ativan dosage.

IV Vitamin Therapy Treatment

Even with a healthy diet, many people lack the necessary daily requirements for optimal health. NRI’s outpatient services include IV Vitamin treatment, which injects the ingredients needed for optimal health directly into the bloodstream for much-needed hydration, vitamins, minerals, and amino acids.

A small catheter is placed into a vein. Then hydration, vitamins, minerals, amino acids and other supplements are administered directly into the bloodstream.

Even with a good healthy diet, most people are depleted of necessary daily requirements for optimal health. People lacking a complete diet, or have underlying medical conditions are already depleted of necessary daily requirements for optimal health. By going directly into the bloodstream, your body can absorb 100% of the contents of your IV Vitamin Therapy. If taken orally, your body is only able to absorb approximately 20% to 30% of the same ingredients.

All of the contents of your IV Vitamin Therapy are FDA-approved and go through high levels of testing. A highly-qualified medical professional (ARNP/CRNA) administers the treatment and under the Medical Director. Prior to treatment, your health history is evaluated. Side effects of treatment are typically non-existent or mild. On occasion, you may experience some slight discomfort, bruising, itching, inflammation, or redness at the site of injection. However, true allergic reactions are extremely rare.

The actual infusion process takes 30 to 45 minutes. There are a few forms to complete prior to the treatment. The entire process typically takes one hour or slightly more.

There really isn’t any. Unlike typical “procedures” there is no requirement in regard to eating or drinking. It is requested you don’t arrive with a very full stomach but you may eat or drink right up to the procedure time. In addition, there is no need for adjunctive medications, such as sedatives, so you may drive yourself to and from your appointment.

The typical infusion offered during outpatient mental health near South Florida is the traditional Myer’s cocktail. It contains many of the nutrients the body needs and will 100% absorb for optimal health including high doses of all B Vitamins, Vitamin C, Magnesium, and Calcium. In addition, we work with a nearby compound pharmacy. We can fulfill specific requests and add to the typical infusion, such as adding glutathione (great for concentration and many other functions), Alpha Lipoic Acid (gaining popularity for weight loss), N-Acetyl Cysteine (for flu, cough, and other lung conditions) and many more.

We pride ourselves on providing the best spa-like experience and catering to your needs. While receiving the treatment, you may relax in our recliners, therapeutic bed, listen to music of your choice, watch our large screen TV with multiple streaming options, and many more comfort options.

Stellate Ganglion Block

The Stellate Ganglion Block is the injection of local anesthetic to the neck that blocks the patient’s “fight or flight” response. As such, it has long proven effective in reducing some of the more severe symptoms of anxiety, trauma, and depression. NRI employs ultrasound-guided placement for enhanced safety during this groundbreaking treatment.

The Stellate Ganglion is a bundle of nerves in the neck that when active, trigger the sympathetic nervous system and initiate the “fight or flight” response leading to increases in heart rate, blood pressure, heightened awareness, and need to be active. The Stellate Ganglion Block is the injection of local anesthetic to the area surrounding the Stellate Ganglion to block the “flight or flight” response feeling.

The SGB has been used for nearly 100 years to relieve chronic pain and depression as well as in the military for PTSD. It is safe and even safer now with the use of ultrasound guided placement to view real time injection.

Along with treating pain, as a regional anesthesia blocks, SGB has also been shown to be an effective treatment for PTSD, Anxiety, and Depression.

Yes. As mentioned previously, for decades, SGB has much research to support SGB to counteract symptoms of depression, PTSD, and trauma. Studies have originated from many reputable institutions.

Immediately after injection, you will feel the arm on injection side getting warm. You may notice any pain decreasing. Additionally, you may also notice a “lump in the throat.”

One single initial injection of local anesthetic to the Stellate Ganglion should last four to six months.

Length of response varies with each patient. Patients may feel symptoms return in the four-to-six-period after the initial injection. As well, patients may receive an additional injection at this four-to-six-month time to stave off a relapse of symptoms and in this same time period thereafter.

Hoarse voice, droopy and red eye, nasal congestion, pupil constriction, flushing of extremities, pain at the injection site. Very rare-–fever or chills, infection, nerve damage, seizure, collapsed lung.

You will arrive at your clinic for outpatient mental health near South Florida, check in, and fill out paperwork on your own and asked questions by your provider as pre-treatment assessments. We take your vital signs and place an IV, and you receive antinausea and sedative meds in the IV. Next, you will be lying on a bed with you head lifted and turned to the side. Lastly, a local anesthetic goes into to the skin for the injection.

Using Ultrasound, a very small needle is placed into the Stellate Ganglion area, where we inject a small amount. The actual SGB injection process takes approximately 15 minutes. After the infusion is completed, you will relax in your bed for approximately 15 to 20 minutes. Then you can be driven home by an arranged driver.

At this time, SGBs are not covered by most insurance providers. While SGB is an FDA-approved regional anesthetic technique and backed by extensive research, it is not yet approved for the treatment of PTSD, anxiety, depression or other psychiatric conditions.

You should not stop taking your psychiatric and other medications at the time of your SGB. You should not adjust dose or frequency of any med without consulting your physician.

Yes. You are not allowed to drive yourself home, so please make arrangements. Do not operate heavy machinery or make any significant life decisions for 24 hrs. Please do not eat a large meal six hours prior to the appointment. You may drink clear liquids up to two hours prior to appointment.

No. You should maintain contact with you psychiatrist, therapist, and/or primary care physician during and after treatment for ongoing medical and mental health needs. SGBs allow the patient to become “unstuck” in rigid negative thought patterns and behaviors. This facilitates the patient in re-engaging in life, the therapeutic process, and allows other psychiatric medications to have an effect.

Experience Superior Mental Health in South Florida

Neuroscience Institute is a premier source of quality addiction treatment and mental health in South Florida. If you or someone you care about is experiencing symptoms of mental health disorder—including anxiety, depression, PTSD, or substance use disorder—our team can help. Contact us today to learn more about our programs and services for outpatient mental health near South Florida.

We Accept Most Insurances

bcbs
humana
aetna
amerihealth
valueoptions
Scroll to Top